NDT Pharmaceuticals Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- James Hovis
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 8400 Old Courthouse Road Vienna VA United States of America 22182
- IPO Date
- Jan 22, 2008
- CIK
- 0001329944
- Website
- ndtpharma.com
- Similar Companies
- Business
- NDT Pharmaceuticals Inc. (NDTP) is a biotechnology company focused on developing nutraceutical and pharmaceutical products utilizing nanoscale particle complex (NPC) technology for advanced delivery systems. The company offers therapies targeting severe neurological disorders associated with traumatic brain injury; NPC-based nano-encapsulation platforms approximately 100 nanometers in diameter, with mean diameters of 40 nanometers in liquid formulations, enabling payload delivery through oral membranes into the bloodstream; and products incorporating Cell Armor for repairing damaged cell tissue. Through its wholly owned subsidiary Good Salt Life, Inc., NDT provides biosafety solutions spanning consumer pet care, home care, cosmetics, antimicrobial chemistry, and chemical delivery systems. Founded in 2005 and headquartered in Vienna, Virginia, with prior references to Liverpool, New York operations, the company targets consumer health, wellness, and hygiene markets primarily in the United States. In September 2025, NDT completed the acquisition of Good Salt Life, Inc., enhancing its portfolio in infection control and biosafety; this move strengthened a key partnership with Norwegian Cruise Line, which increased orders for Good Salt's technology, positioning NDT to expand into hospitality, healthcare, and transportation sectors.
NDT Pharmaceuticals Inc.'s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant
NDT Pharmaceuticals' Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant
NDT Pharmaceuticals, Inc.'s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals
Good Salt Life, Inc.'s Induction Charge Delivery Systems Deployed to Protect Show Horses from Widespread EHV-1 Outbreak
NDT Pharmaceuticals' Subsidiary, Good Salt(TM) Life, Secures Major Government Contract, Deploying Advanced Biosafety Ecosystem in Tennessee State Prisons
NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line
Baptist Hospital Enhances Patient Safety and Air Quality with Good Salt(TM) Life's ByoCart(TM) Disinfection System
Good Salt Life Expands EPA Registrations and Anticipates New Milestone
NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets